Please click on "Add to Cart" to obtain the white paper on "Expanding a Product Portfolio without Cannibalizing an Established Brand."
Owing to mounting competition, bio-pharmaceutical companies often expand their product portfolio in the same indication area. This may lead a new brand into gaining more popularity at the expense of an established brand. The challenge for all product and brand leaders is to expand their product portfolio such that introduction of a new product does not affect the sales of the established brand.
This white paper contains key excerpts from Best Practices, LLC benchmarking reports which are aimed at providing superior marketing and branding strategies.
If you would like to purchase the full study this summary is based on click here.